Challenging biopower: "liquid cuffs" and the "junkie" habitus

Drugs: Education, Prevention and Policy

Volumn 22, Issue 3, 2015, Pages 248-254

  Gelpi Acosta, Camila ^a  

^a University of New York   (United States)

Author keywords

Disciplinary biopower; habitus; heroin; Junkie; methadone; methadone programs

Indexed keywords

EID: 84938840429     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687637.2014.987219     Document Type: Article

References (35)

1. Ball, J. C., & Corty, E. (1988). Basic issues pertaining to the effectiveness of methadone maintenance system NIDA research monograph 86:178-91
2. Ball, J. C., Lange, W. R., Meyers, C. P., & Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. The Journal of Health and Social Behavior, 29, 214-226
3. Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York: Spring-Verlag
4. Bourdieu, P. (1990). The logic of practice. California: Polity Press
5. Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24, 165-195
6. Bourgois, P., & Schonberg, J. (2009). Righteous dopefiend. California: University of California Press
7. Deck, D., Carlson, M. J. (2005). Retention in publicly funded methadone maintenance treatment in two western states. The Journal of Behavioral Health Services and Research, 21, 43-60
8. Dole, V., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride. Journal of American Medical Association, 193, 646-650
9. Foucault, M. (1990). The history of sexuality. Volume 1: An introduction. New York: Vintage Books
10. Gartry, C. C., Oviedo-Joekes, E., Laliberté, N., & Schechter, M. T. (2009). NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America. Harm Reduction Journal, 6, 2
11. Glaser, BG., Strauss, AL. (1967). The discovery of grounded theory: Strategies for qualitative research. New Brunswick, NJ and London, UK: Aldine Transaction
12. Heller, D. I., & Stancliff, S. (2003). Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City. Public Health Reports, 122, 393-397
13. Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., Ginzburg, H. M. (1989). Drug abuse treatment a national study of effectiveness. Chapel Hill: The University of North Carolina Press
14. Joseph, H., & Stancliff, S. (2000). Methadone maintenance treatment: A review of historical and clinical issues. The Mount Sinai Journal of Medicine, 67, 347-364
15. Keane, H. (2009). Foucault on methadone: Beyond biopower. International Journal of Drug Policy, 20, 450-452
16. Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of addiction: Methadone. Journal of Addiction Disorders, 29, 200-216
17. Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. The Mount Sinai Journal of Medicine, 68, 62-74
18. Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug and Alcohol Dependence, 99, 222-230
19. Magura, S., Rosenblum, A., Fong, C., Villano, C., & Richman, B. (2002). Treating cocaine-using methadone patients: Predictors of outcomes in a psychosocial clinical trial. Substance Use and Misuse, 37, 1927-1955
20. Magura, S., Nwakeze, P. C., & Demsky, S. (1998). Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51-60
21. National Institutes on Drug Abuse (NIDA). (2010). Drugs, brains and behavior: The science of addiction. National Institutes on Drug Abuse. Retrieved from http://www.drugabuse. gov/publications/scienceaddiction
22. Office of Alcohol and Substance Abuse Services, Part 822, Subpart 822-5. Retrieved on April 23 2014 from http://www.oasas. ny. gov/mis/forms/reg/822/part822. cfm
23. Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed. ). Thousand Oaks, London, New Delhi: Sage
24. Peterson, J. A., Schwartz, R. P., Mitchell, S. G., Reisinger, H. S., Kelly, S. M., O'Grady, K. E. Agar, M. H. (2010). Why don't outof-treatment individuals enter methadone treatment programs? International Journal of Drug Policy, 21, 36-42
25. Pollack, H., & D'Aunno, T. (2008). Dosage patterns in methadone treatment: Results from a National survey 1988-2005. Health Services Research, 43, 2143-2163
26. Reisinger, H. S., Schwartz, R. P., Mitchell, S. G., Peterson, J. A., Kelly, S. M., O'Grady, K. E. Agar, M. H. (2009). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs, 41, 285-296
27. Rosenblum, A., Parrino, M., Schnoll, S. H., Fong, C., Maxwell, C., Cleland, C. M. Haddox, D. J. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90, 64-71
28. Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Peterson, J. A., Reisinger, H. S., Mitchell, S. G. Brown BS. (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse, 34, 17-28
29. Simpson, D. D., & Sells, S. B. (1982) Effectiveness of Treatment for Drug Use: An Overview of the DARP Research Program. Advances in Alcohol and Substance Abuse, 2, 7-29
30. Simpson, D. D., & Sells, S. B. (1983). Effectiveness of treatment for drug abuse: An overview of the DARP Research Program. Hawthorn Press
31. Stancliff, S., Myers, J. E., Steiner, S., & Drucker, E. (2002). Beliefs about methadone in an inner-city methadone clinic. Journal of Urban Health, 79, 571-578
32. Stotts, A., Dodrill, C. L., & Kosten, T. R. (2010). Opioid dependence treatment: Options in pharmacology. Expert Opinions in Pharmacotherapy, 10, 1727-1740
33. Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate-vs high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA, 281, 1000-1005
34. van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W., van Zwieten, B. J., & van Ree, J. M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal, 327, 310-315
35. Zinberg, N. (1984). Drug, set, setting: The basis for controlled intoxicant use. New Haven: Yale University Press